What is the appropriate ivermectin dosing regimen for treating scabies, including dose amount, repeat interval, and special patient considerations?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ivermectin Dosing for Scabies

For uncomplicated scabies, administer oral ivermectin 200 mcg/kg on day 0 and repeat on day 14 (two weeks later), taken with food. 1

Standard Dosing Regimen

The CDC STD Treatment Guidelines establish the foundational dosing approach 1:

  • Dose: 200 mcg/kg orally
  • Timing: Two doses, 14 days apart
  • Administration: Must be taken with food (increases bioavailability by approximately 2.5-fold, enhancing epidermal penetration) 1

The second dose is critical. Ivermectin has limited ovicidal activity and does not kill eggs present at initial treatment 1. Recent evidence strongly supports this: a 2023 study demonstrated 98% cure rate with two doses versus only 58% with a single dose (P < 0.001) 2. The absence of a second dose is one of the main predictors of treatment failure and may increase resistance development 2.

Weight-Based Dosing Table

Using the FDA-approved strongyloidiasis dosing as reference (adapted for scabies at 200 mcg/kg) 3:

  • 15-24 kg: 1 tablet (3 mg)
  • 25-35 kg: 2 tablets (6 mg)
  • 36-50 kg: 3 tablets (9 mg)
  • 51-65 kg: 4 tablets (12 mg)
  • 66-79 kg: 5 tablets (15 mg)
  • ≥80 kg: Calculate 200 mcg/kg

Special Patient Populations

Children and Infants

  • Children ≥15 kg: Standard 200 mcg/kg dosing, repeated in 14 days 1
  • **Children <15 kg**: Safety not established in FDA labeling 3, though recent research shows safety and efficacy at >200 mcg/kg doses in children 4-14.5 kg with only 4% mild adverse events 4. However, permethrin remains the guideline-recommended first-line treatment for this population 1
  • Infants <3 months: Insufficient data; use permethrin

Pregnancy and Lactation

Permethrin is the preferred treatment 1. Ivermectin is classified as "human data suggest low risk" and probably compatible with breastfeeding, but limited data make permethrin preferable 1.

Immunocompromised Patients (Including HIV)

HIV-positive patients with uncomplicated scabies receive the same regimen as HIV-negative patients 1. However, they are at increased risk for crusted scabies and should be monitored closely.

Crusted (Norwegian) Scabies

This requires intensive combination therapy 1:

  • Ivermectin 200 mcg/kg orally on days 1,2,8,9, and 15
  • Plus topical permethrin 5% or benzyl benzoate 5% applied daily for 7 days, then twice weekly until cure
  • Additional ivermectin doses on days 22 and 29 may be required for severe cases 1
  • Manage in consultation with a specialist 1

Renal and Hepatic Considerations

  • Renal impairment: No dose adjustment required 1
  • Severe liver disease: Safety of multiple doses unknown; use with caution 1

Common Pitfalls to Avoid

  1. Forgetting the second dose: This is the most common cause of treatment failure 2, 5
  2. Not taking with food: Significantly reduces bioavailability 1
  3. Inadequate environmental decontamination: Bedding and clothing must be machine-washed/dried on hot cycle or removed from body contact for 72 hours 1
  4. Not treating household contacts: All sexual, close personal, or household contacts within the preceding month should be treated simultaneously 1
  5. Premature retreatment: Pruritus may persist up to 2 weeks post-treatment due to allergic dermatitis, not treatment failure 1

When to Retreat

Consider retreatment at 2 weeks if 1:

  • Symptoms persist beyond 2 weeks
  • Live mites are observed
  • Use an alternative regimen if initial treatment fails

Comparative Efficacy Note

While ivermectin is effective, a 2026 cluster randomized trial showed 5% permethrin cream superior to ivermectin (88.5% vs 71.8% cure rate) when both were given on days 0 and 10 6. However, ivermectin remains valuable for patients who cannot tolerate topicals, in institutional outbreaks, and when adherence to topical therapy is problematic 7, 8.

Monitoring

Follow-up evaluation should occur if symptoms persist beyond 2 weeks. New eczematous eruptions may appear within 72 hours of ivermectin administration (reported in 47.8% of patients in one study), which respond to topical corticosteroids 9.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.